These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3478286)

  • 21. Coagulation testing with the Du Pont aca discrete clinical analyzer.
    Pierson-Perry JF; Wehrly JA; Siefring GE
    Semin Thromb Hemost; 1983 Oct; 9(4):321-33. PubMed ID: 6658463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis of increased thrombotic tendency with chromogenic substrates].
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):135-41. PubMed ID: 6177594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the automated coagulation analyzer Sysmex CA-7000.
    Fischer F; Appert-Flory A; Jambou D; Toulon P
    Thromb Res; 2006; 117(6):721-9. PubMed ID: 16098565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the automated coagulation analyzer Sysmex(®) CS-2100i (Siemens)].
    Martin-Toutain I; Jobic L; Mancic T; Ankri A
    Ann Biol Clin (Paris); 2011; 69(6):699-704. PubMed ID: 22123571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood clotting diagnosis with chromogenic substrates].
    Róka L; Rasche H
    Internist (Berl); 1980 Apr; 21(4):189-94. PubMed ID: 6998907
    [No Abstract]   [Full Text] [Related]  

  • 26. Newer avenues in the monitoring of antithrombotic therapy: the role of automation.
    Walenga JM; Fareed J; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):346-54. PubMed ID: 6658465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 28. Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery.
    Kongsgaard UE; Smith-Erichsen N; Geiran O; Bjørnskau L
    Thorac Cardiovasc Surg; 1989 Jun; 37(3):158-62. PubMed ID: 2527423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of antithrombin III in normal and pathologic states using chromogenic substrate S-2238. Comparison with immunoelectrophoretic and factor Xa inhibition assays.
    Goodnight SH; Schaeffer JL; Sheth K
    Am J Clin Pathol; 1980 May; 73(5):639-47. PubMed ID: 7377131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a centrifugal analyzer in coagulation testing.
    Hills LP; Lorenzi-Anderson M; Huey EE; Tiffany TO
    Semin Thromb Hemost; 1983 Jul; 9(3):217-27. PubMed ID: 6612352
    [No Abstract]   [Full Text] [Related]  

  • 31. Antithrombin III and plasminogen: a comparison of two synthetic substrate-based methods.
    Ito RK; Statland BE
    Am J Clin Pathol; 1983 Oct; 80(4):465-73. PubMed ID: 6624709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a fully automated centrifugal analyzer for performance of hemostasis tests.
    Chantarangkul V; Tripodi A; Mannucci PM
    Clin Chem; 1987 Oct; 33(10):1888-90. PubMed ID: 3665045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a centrifugal analyzer for a chromogenic prothrombin time, a chromogenic activated partial thromboplastin time and a kinetic fibrinogen assay in a routine hospital laboratory.
    de Metz M; van Wersch JW
    Haemostasis; 1987; 17(5):254-9. PubMed ID: 3666583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients.
    Cordova C; Musca A; Violi F; Alessandri C; Ferro D; Piromalli A; Balsano F
    Haemostasis; 1984; 14(2):218-22. PubMed ID: 6564063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The determination of inhibitors of haemostasis using chromogenic substances (author's transl)].
    Jürgens H; von Voss H; Göbel U
    Klin Padiatr; 1980 Jul; 192(4):330-5. PubMed ID: 7192767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of anaesthesia on coagulation and fibrinolytic proteins.
    Richard LC; Büller HR; Bovilland J; ten Cate JW
    Br J Anaesth; 1983 Sep; 55(9):869-72. PubMed ID: 6615674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic.
    Topper MJ; Prasse KW
    Am J Vet Res; 1996 Apr; 57(4):456-62. PubMed ID: 8712506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunochemical determination of thrombin-antithrombin III and plasmin-antiplasmin complexes in human plasma.
    Collen D
    Verh K Acad Geneeskd Belg; 1979; 41(2):81-166. PubMed ID: 160714
    [No Abstract]   [Full Text] [Related]  

  • 39. Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.
    Kahle LH; Avvisati G; Lamping RJ; Moretti T; Mandelli F; ten Cate JW
    Scand J Clin Lab Invest Suppl; 1985; 178():75-80. PubMed ID: 2418490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of several chromogenic substrate assays to automated instrumentation for coagulation analysis.
    Bartl K; Becker U; Lill H
    Semin Thromb Hemost; 1983 Oct; 9(4):301-8. PubMed ID: 6658461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.